Our previous study [28] demonstrated that isorhamnetin can modulate the expression of several drug-resistance-associated ABC transporters, including P-gp in DLD-1 and HCT-116 colon cancer cells, thereby influencing cellular drug efflux and resistance development. This evidence concerns the gene ABCG2 and colonic neoplasm.